What is IMMNOV.ST's gross margin?

Immunovia AB (IMMNOV.ST) has a gross margin of 36% and a net margin of -5992%.

What is IMMNOV.ST's P/E ratio?

Track Immunovia AB (IMMNOV.ST) P/E ratio, ROE, and valuation metrics over time.

Where can I see IMMNOV.ST's full financials?

See Immunovia AB (IMMNOV.ST) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Immunovia AB (IMMNOV.ST) Financials — Revenue, Earnings, Cash Flow

Also trades as: 0G8X.L (LSE) · $vol 0M · IMMVF (OTC) · $vol 0M

kr 0.08 ($0.01)

-0.01 (-10.59%)

Weekly Expected Move ±24.2%

kr 0 kr 0 kr 0 kr 0 kr 0

STO · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Sell · Power 32 · kr 26.0M mcap · 332M float · 0.993% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers

📊 Key Metrics

TTM

kr 1M

Revenue

+31.7% YoY

kr -88M

Net Income

+39.8% YoY

kr -83M

Free Cash Flow

+5.9% YoY

36.5%

Gross Margin

-6004.7%

Op. Margin

-5991.9%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-427.0%

ROA-213.2%

ROIC816.7%

Valuation

P/E-0.5

P/B2.2

EV/EBITDA-1.2

Leverage

Debt/Equity0.14

Current Ratio1.57

Interest Cov.-13.3x

Quality Scores

Piotroski F3/9

Altman Z-40.56

Beneish M0.61